News Sentiment

GNTA sentiment intelligence

Genenta Science SpA ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.50 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-12.8% over one week, -19.8% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Genenta Science Regains Full Effectiveness of Corporate Purpose Amendment After Milan Court Ruling

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -12.8% Price reacting lower
Trend fit Trend active -19.8% over four weeks
Fair value -57.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 31
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 8
TradingView 8
Market source 6
The Globe and Mail 5
TradingKey 5
dars.gov.et 2
DonanımHaber 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 16
Deals and strategy 2
Analyst action 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-48 of 48
StocksToTrade Direct company coverage

GNTA Stock Explodes On Volume As Traders Scan Biotech Charts

Genenta Science S.p.A. (GNTA) stock surged by 85.5%, driven by regulatory and clinical progress, turning it into a low-float momentum play for active traders. Despite its small revenue, GNTA has a solid balance sheet and trades near its book value, making its chart action and vol

Tone
Positive 72/100
Event
Earnings
Published
01 Jun 2026 10:02
Source
StocksToTrade
The Globe and Mail Direct company coverage

Genenta Science Closes All-Share Acquisition of Remaining Stake in A.T.C.

Genenta Science has completed an all-share acquisition of the remaining 80.5% stake in A.T.C. S.r.l., solidifying its full ownership. The €9.6 million purchase was settled by issuing new Genenta ordinary shares to A.T.C. shareholders, who are subject to a 36-month lock-up period

Tone
Positive 75/100
Event
Deals and strategy
Published
31 May 2026 13:08
Source
The Globe and Mail
Stock Titan Direct company coverage

Genenta Science (GNTA) takes full control by acquiring remaining 80.5% of A.T.C.

Genenta Science (GNTA) has acquired the remaining 80.5% equity ownership of A.T.C. S. from its existing shareholders, taking full control. The transaction, finalized on May 29, 2026, was governed by an Amendment Agreement and approved by Genenta's board on May 18, 2026. Key terms

Tone
Positive 67/100
Event
Market update
Published
29 May 2026 19:38
Source
Stock Titan